SpringWorks Therapeutics Ownership

SWTXDelisted Stock  USD 46.99  0.00  0.00%   
SpringWorks Therapeutics shows a total of 75.35 Million outstanding shares. The majority of SpringWorks Therapeutics outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in SpringWorks Therapeutics to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in SpringWorks Therapeutics. Please pay attention to any change in the institutional holdings of SpringWorks Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as SpringWorks Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of SpringWorks Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

SpringWorks Stock Ownership Analysis

About 87.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.41. SpringWorks Therapeutics had not issued any dividends in recent years. SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut. Springworks Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people. To find out more about SpringWorks Therapeutics contact Saqib JD at 203 883 9490 or learn more at https://www.springworkstx.com.

SpringWorks Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SpringWorks Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on SpringWorks Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SpringWorks Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Badreddin Edris over six months ago
Disposition of 12078 shares by Badreddin Edris of SpringWorks Therapeutics at 54.2582 subject to Rule 16b-3
 
Islam Saqib over six months ago
Disposition of 600 shares by Islam Saqib of SpringWorks Therapeutics at 56.89 subject to Rule 16b-3
 
Islam Saqib over six months ago
Disposition of 30756 shares by Islam Saqib of SpringWorks Therapeutics at 53.41 subject to Rule 16b-3
 
Weinstein Herschel S over six months ago
Disposition of 3575 shares by Weinstein Herschel S of SpringWorks Therapeutics at 38.19 subject to Rule 16b-3
 
Cassidy James over six months ago
Disposition of 1658 shares by Cassidy James of SpringWorks Therapeutics at 38.86 subject to Rule 16b-3
 
Cassidy James over six months ago
Disposition of 3465 shares by Cassidy James of SpringWorks Therapeutics at 38.19 subject to Rule 16b-3
 
Hambleton Julie over a year ago
Acquisition by Hambleton Julie of 12216 shares of SpringWorks Therapeutics at 44.77 subject to Rule 16b-3
 
Badreddin Edris over a year ago
Disposition of 8034 shares by Badreddin Edris of SpringWorks Therapeutics at 42.2447 subject to Rule 16b-3
 
Badreddin Edris over a year ago
Disposition of 4192 shares by Badreddin Edris of SpringWorks Therapeutics at 40.6219 subject to Rule 16b-3
 
Lin Tai-an over a year ago
Disposition of 2324 shares by Lin Tai-an of SpringWorks Therapeutics at 32.83 subject to Rule 16b-3
 
Badreddin Edris over a year ago
Disposition of 3080 shares by Badreddin Edris of SpringWorks Therapeutics at 42.075 subject to Rule 16b-3
 
Cassidy James over a year ago
Disposition of 1969 shares by Cassidy James of SpringWorks Therapeutics at 41.71 subject to Rule 16b-3

SpringWorks Therapeutics Outstanding Bonds

SpringWorks Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SpringWorks Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SpringWorks bonds can be classified according to their maturity, which is the date when SpringWorks Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in SpringWorks Stock

If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes